APA (7th ed.) Citation

K, A., H, T., M, F., T, Y., D, T., R, T., . . . H, M. (2026). Phase I study of amrubicin plus cisplatin and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-stage small cell lung cancer. Lung cancer (Amsterdam, Netherlands), 214, 109310. https://doi.org/10.1016/j.lungcan.2026.109310

Chicago Style (17th ed.) Citation

K, Akagi, et al. "Phase I Study of Amrubicin Plus Cisplatin and Concurrent Accelerated Hyperfractionated Thoracic Radiotherapy for Limited-stage Small Cell Lung Cancer." Lung Cancer (Amsterdam, Netherlands) 214 (2026): 109310. https://doi.org/10.1016/j.lungcan.2026.109310.

MLA (9th ed.) Citation

K, Akagi, et al. "Phase I Study of Amrubicin Plus Cisplatin and Concurrent Accelerated Hyperfractionated Thoracic Radiotherapy for Limited-stage Small Cell Lung Cancer." Lung Cancer (Amsterdam, Netherlands), vol. 214, 2026, p. 109310, https://doi.org/10.1016/j.lungcan.2026.109310.